MedTrace Logo

OptiCal Study -Optimizing Fecal Calprotectin Monitoring: a Clinical Study Comparing CalproLab Against PhiCal and Evaluating Its Association With the Gut Microbiome

NCT03051204 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 175

Last updated 2023-09-22

No results posted yet for this study

Summary

Study Aims:

To analyze stool specimens to test and validate the CalproLab assay against the predicate PhiCal in order to determine performance characteristics.

And to correlate Calpro levels to the gut microbiome composition.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Daniel Hommes, MD · UCLA IBD CENTER

Eligibility

Min Age
4 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-28
Primary Completion
2018-12-11
Completion
2018-12-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03051204 on ClinicalTrials.gov